Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gotch

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
HIV Medicine|December 12, 2001
T-cell telomere length maintained in HIV-infected long-term survivorsV Tucker, J Jenkins, J Gilmour, et al.
Journal of Immune Based Therapies and Vaccines|September 27, 2005
Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapyA Pires, M Nelson, A L Pozniak, et al.
European Journal of Immunology|April 1, 1992
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytesJ Morrison, J Elvin, F Latron, et al.
The British Journal of Dermatology|December 21, 2000
HLA-C and guttate psoriasisE Mallon, M Bunce, H Savoie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Effect of intradialytic parenteral nutrition on delivered Kt/VL McCann, C Feldman, J Hornberger, et al.
Journal of Molecular Evolution|April 20, 2004
Recombination does not occur in newly identified diverged oceanic picornavirusesG Greenspan, D Geiger, F Gotch, et al.
Nature|May 31, 1990
Presentation of viral antigen controlled by a gene in the major histocompatibility complexV Cerundolo, J Alexander, K Anderson, et al.
Journal of Molecular Evolution|March 27, 2004
Model-based inference of recombination hotspots in a highly variable oncogene [corrected]G Greenspan, D Geiger, F Gotch, et al.
HIV Medicine|January 21, 2004
Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well toleratedS Portsmouth, N Imami, A Pires, et al.
Immunology Letters|October 12, 2001
Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccinationN Imami, G Hardy, C Burton, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
HIV Medicine|December 12, 2001
T-cell telomere length maintained in HIV-infected long-term survivorsV Tucker, J Jenkins, J Gilmour, et al.
Journal of Immune Based Therapies and Vaccines|September 27, 2005
Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapyA Pires, M Nelson, A L Pozniak, et al.
European Journal of Immunology|April 1, 1992
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytesJ Morrison, J Elvin, F Latron, et al.
The British Journal of Dermatology|December 21, 2000
HLA-C and guttate psoriasisE Mallon, M Bunce, H Savoie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Effect of intradialytic parenteral nutrition on delivered Kt/VL McCann, C Feldman, J Hornberger, et al.
Journal of Molecular Evolution|April 20, 2004
Recombination does not occur in newly identified diverged oceanic picornavirusesG Greenspan, D Geiger, F Gotch, et al.
Nature|May 31, 1990
Presentation of viral antigen controlled by a gene in the major histocompatibility complexV Cerundolo, J Alexander, K Anderson, et al.
Journal of Molecular Evolution|March 27, 2004
Model-based inference of recombination hotspots in a highly variable oncogene [corrected]G Greenspan, D Geiger, F Gotch, et al.
HIV Medicine|January 21, 2004
Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well toleratedS Portsmouth, N Imami, A Pires, et al.
Immunology Letters|October 12, 2001
Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccinationN Imami, G Hardy, C Burton, et al.
Pageof 10